In this case study, find out how OPTEL GROUP, the leading global provider of traceability systems in the healthcare industry, partnered with the Oxford University Hospitals NHS Foundation Trust, a world-renowned centre of clinical excellence and one of the largest NHS teaching trusts in the UK, to carry out an eight-week pilot project to test its user-friendly solution to immediately comply with the requirements of the upcoming European Union Falsified Medicines Directive (EU FMD).

Please fill this form to download your case study